260 related articles for article (PubMed ID: 15855257)
21. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients.
Attanasio AF; Shavrikova E; Blum WF; Cromer M; Child CJ; Paskova M; Lebl J; Chipman JJ; Shalet SM;
J Clin Endocrinol Metab; 2004 Oct; 89(10):4857-62. PubMed ID: 15472176
[TBL] [Abstract][Full Text] [Related]
22. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.
Koranyi J; Svensson J; Götherström G; Sunnerhagen KS; Bengtsson B; Johannsson G
J Clin Endocrinol Metab; 2001 Oct; 86(10):4693-9. PubMed ID: 11600527
[TBL] [Abstract][Full Text] [Related]
23. Moderate doses of hGH (0.64 mg/d) improve lipids but not cardiovascular function in GH-deficient adults with normal baseline cardiac function.
Newman CB; Frisch KA; Rosenzweig B; Roubenoff R; Rey M; Kidder T; Kong Y; Pursnani A; Sedlis SP; Schwartzbard A; Kleinberg DL
J Clin Endocrinol Metab; 2011 Jan; 96(1):122-32. PubMed ID: 20926529
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone action in puberty: effects by gender.
Mauras N; Bishop K; Welch S
Growth Horm IGF Res; 2007 Dec; 17(6):463-71. PubMed ID: 17566776
[TBL] [Abstract][Full Text] [Related]
25. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study.
Toogood AA; Shalet SM
J Clin Endocrinol Metab; 1999 Jan; 84(1):131-6. PubMed ID: 9920073
[TBL] [Abstract][Full Text] [Related]
27. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
[TBL] [Abstract][Full Text] [Related]
28. Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms.
Kehely A; Bates PC; Frewer P; Birkett M; Blum WF; Mamessier P; Ezzat S; Ho KK; Lombardi G; Luger A; Marek J; Russell-Jones D; Sönksen P; Attanasio AF
J Clin Endocrinol Metab; 2002 May; 87(5):1974-9. PubMed ID: 11994327
[TBL] [Abstract][Full Text] [Related]
29. Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly.
Norrman LL; Johannsson G; Sunnerhagen KS; Svensson J
J Clin Endocrinol Metab; 2008 Jul; 93(7):2531-8. PubMed ID: 18397981
[TBL] [Abstract][Full Text] [Related]
30. Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults.
Gibney J; Healy ML; Stolinski M; Bowes SB; Pentecost C; Breen L; McMillan C; Russell-Jones DL; Sonksen PH; Umpleby AM
J Clin Endocrinol Metab; 2003 Apr; 88(4):1792-7. PubMed ID: 12679475
[TBL] [Abstract][Full Text] [Related]
31. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients.
Attanasio AF; Howell S; Bates PC; Frewer P; Chipman J; Blum WF; Shalet SM
J Clin Endocrinol Metab; 2002 Jul; 87(7):3368-72. PubMed ID: 12107251
[TBL] [Abstract][Full Text] [Related]
32. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
[TBL] [Abstract][Full Text] [Related]
33. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
Bramnert M; Segerlantz M; Laurila E; Daugaard JR; Manhem P; Groop L
J Clin Endocrinol Metab; 2003 Apr; 88(4):1455-63. PubMed ID: 12679422
[TBL] [Abstract][Full Text] [Related]
35. Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function.
Jørgensen JO; Nørrelund H; Vahl N; Juul A; Skakkebaek NE; Christiansen JS
J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1355-60. PubMed ID: 12510991
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
[TBL] [Abstract][Full Text] [Related]
37. Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement.
Gómez JM; Gómez N; Fiter J; Soler J
Horm Metab Res; 2000 Feb; 32(2):66-70. PubMed ID: 10741688
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
39. Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults.
Götherström G; Elbornsson M; Stibrant-Sunnerhagen K; Bengtsson BA; Johannsson G; Svensson J
J Clin Endocrinol Metab; 2009 Mar; 94(3):809-16. PubMed ID: 19088164
[TBL] [Abstract][Full Text] [Related]
40. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
Sas T; Mulder P; Hokken-Koelega A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
